Elnas, Hansel R.
HRN: 13-34-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/01/2025
04/03/2025
IV
4.5g
Q6hr
Sp CS With Hysterectomy; TC HAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes